146 related articles for article (PubMed ID: 19866451)
1. Outcomes for lymphoid malignancies in the Nurses' Health Study (NHS) as compared to the Surveillance, Epidemiology and End Results (SEER) Program.
Abel GA; Bertrand KA; Earle CC; Laden F
Hematol Oncol; 2010 Sep; 28(3):133-6. PubMed ID: 19866451
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
3. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
5. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
6. [Inheritance in lymphoproliferative disorders].
Jønsson V; Olsen JH
Ugeskr Laeger; 2006 Jun; 168(24):2361-6. PubMed ID: 16822421
[TBL] [Abstract][Full Text] [Related]
7. [Health databases to assess the incidence of lymphoid malignancies in Italian population].
Borciani N; Vinceti M; Avanzini P; Ilariucci F; Mangone L; Martini M; Merlin M; Ferretti A; Frassineti M; Rodolfi R; Bergomi M
Epidemiol Prev; 2000; 24(2):81-4. PubMed ID: 10863849
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic and lymphoproliferative cancer among male veterans using the Veterans Administration Medical System.
Namboodiri KK; Harris RE
Cancer; 1991 Sep; 68(5):1123-30. PubMed ID: 1913485
[TBL] [Abstract][Full Text] [Related]
9. Lympho-hemopoietic malignancies in India.
Bhutani M; Vora A; Kumar L; Kochupillai V
Med Oncol; 2002; 19(3):141-50. PubMed ID: 12482124
[TBL] [Abstract][Full Text] [Related]
10. Secondary myeloma in patients with chronic lymphoblastic leukemia: A case report and analysis of data from SEER database.
Lin Z; Chen X; Huang Y; Zhao H; Li Z; Xu B
Curr Probl Cancer; 2021 Oct; 45(5):100728. PubMed ID: 33752897
[TBL] [Abstract][Full Text] [Related]
11. Profiles and prognostic values of serum LDH isoenzymes in patients with haematopoietic malignancies.
Bouafia F; Drai J; Bienvenu J; Thieblemont C; Espinouse D; Salles G; Coiffier B
Bull Cancer; 2004; 91(7-8):E229-40. PubMed ID: 15381461
[TBL] [Abstract][Full Text] [Related]
12. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
Oncologist; 2019 Sep; 24(9):1219-1228. PubMed ID: 30808814
[TBL] [Abstract][Full Text] [Related]
13. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database.
Altieri A; Bermejo JL; Hemminki K
Blood; 2005 Jul; 106(2):668-72. PubMed ID: 15811955
[TBL] [Abstract][Full Text] [Related]
14. Adulthood residential ultraviolet radiation, sun sensitivity, dietary vitamin D, and risk of lymphoid malignancies in the California Teachers Study.
Chang ET; Canchola AJ; Cockburn M; Lu Y; Wang SS; Bernstein L; Clarke CA; Horn-Ross PL
Blood; 2011 Aug; 118(6):1591-9. PubMed ID: 21622649
[TBL] [Abstract][Full Text] [Related]
15. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
[TBL] [Abstract][Full Text] [Related]
16. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
[TBL] [Abstract][Full Text] [Related]
17. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
Xavier AC; Armeson KE; Hill EG; Costa LJ
Cancer; 2013 Sep; 119(18):3385-92. PubMed ID: 23797978
[TBL] [Abstract][Full Text] [Related]
18. Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.
Ali S; Olszewski AJ
Leuk Lymphoma; 2014 Jul; 55(7):1570-7. PubMed ID: 24067135
[TBL] [Abstract][Full Text] [Related]
19. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
[TBL] [Abstract][Full Text] [Related]
20. Survival patterns among lymphoma patients with a family history of lymphoma.
Anderson LA; Pfeiffer RM; Rapkin JS; Gridley G; Mellemkjaer L; Hemminki K; Björkholm M; Caporaso NE; Landgren O
J Clin Oncol; 2008 Oct; 26(30):4958-65. PubMed ID: 18606984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
